Published in Arthritis Res Ther on September 30, 2011
JAK3-STAT pathway blocking benefits in experimental lupus nephritis. Arthritis Res Ther (2016) 1.38
Requirement for MyD88 signaling in B cells and dendritic cells for germinal center anti-nuclear antibody production in Lyn-deficient mice. J Immunol (2013) 1.09
Contribution of Toll-like receptor signaling to germinal center antibody responses. Immunol Rev (2012) 1.02
Exonuclease TREX1 degrades double-stranded DNA to prevent spontaneous lupus-like inflammatory disease. Proc Natl Acad Sci U S A (2015) 1.00
Genetic variations in Toll-like receptors (TLRs 3/7/8) are associated with systemic lupus erythematosus in a Taiwanese population. Sci Rep (2014) 0.92
Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy. Arthritis Res Ther (2013) 0.90
Treatment targets in systemic lupus erythematosus: biology and clinical perspective. Arthritis Res Ther (2012) 0.90
B Cell in Autoimmune Diseases. Scientifica (Cairo) (2012) 0.90
A diverse array of genetic factors contribute to the pathogenesis of systemic lupus erythematosus. Orphanet J Rare Dis (2013) 0.87
Disease activity in systemic lupus erythematosus correlates with expression of the transcription factor AT-rich-interactive domain 3A. Arthritis Rheumatol (2014) 0.85
Fueling autoimmunity: type I interferon in autoimmune diseases. Expert Rev Clin Immunol (2013) 0.84
Interferon-inducible Ifi200-family genes as modifiers of lupus susceptibility. Immunol Lett (2012) 0.84
Systemic lupus erythematosus and granulomatous lymphadenopathy. BMC Pediatr (2013) 0.79
Pivotal Functions of Plasmacytoid Dendritic Cells in Systemic Autoimmune Pathogenesis. J Clin Cell Immunol (2014) 0.79
Regulation of basement membrane-reactive B cells in BXSB, (NZBxNZW)F1, NZB, and MRL/lpr lupus mice. Autoimmunity (2013) 0.79
MicroRNA-let-7a promotes E2F-mediated cell proliferation and NFκB activation in vitro. Cell Mol Immunol (2013) 0.78
Interleukin-6 receptor alpha blockade improves skin lesions in a murine model of systemic lupus erythematosus. Exp Dermatol (2016) 0.76
Systemic lupus erythematosus with hepatosplenic granuloma: a rare case. Case Reports Immunol (2014) 0.75
Pathways leading to an immunological disease: systemic lupus erythematosus. Rheumatology (Oxford) (2017) 0.75
Mitochondrial Control and Guidance of Cellular Activities of T Cells. Front Immunol (2017) 0.75
Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med (2003) 11.23
Pathogenesis of the glomerulonephritis of NZB/W mice. J Exp Med (1968) 8.91
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet (1998) 8.20
Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med (1999) 7.41
DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol (2002) 6.85
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature (2000) 6.54
Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature (2001) 6.31
Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science (2006) 5.30
Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci U S A (2010) 5.05
Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med (2005) 4.92
Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science (2001) 4.42
Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest (2005) 3.93
Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med (1999) 3.88
Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med (2002) 3.83
A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med (1999) 3.74
A DNA-reacting factor in serum of a patient with lupus erythematosus diffusus. Proc Soc Exp Biol Med (1957) 3.59
Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity (2000) 3.55
Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J Exp Med (2005) 3.43
Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum (1998) 3.41
Activation of autoreactive B cells by CpG dsDNA. Immunity (2003) 3.40
Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med (1996) 3.36
Dendritic cell apoptosis in the maintenance of immune tolerance. Science (2006) 3.33
Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell (1995) 3.17
Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med (1998) 3.01
In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon. J Exp Med (1987) 2.93
The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol (2004) 2.67
The role of B cells in lpr/lpr-induced autoimmunity. J Exp Med (1994) 2.61
Regulation of B cell tolerance by the lupus susceptibility gene Ly108. Science (2006) 2.58
Pathologic mechanisms in neutrophil-mediated injury. Am J Pathol (1972) 2.57
Abrogation of macrophage-dependent injury in experimental glomerulonephritis in the rabbit. Use of an antimacrophage serum. J Clin Invest (1981) 2.41
Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN. J Immunol (2006) 2.38
Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J Clin Invest (2005) 2.36
Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev (2007) 2.22
Roles of interferon-gamma and interleukin-4 in murine lupus. J Clin Invest (1997) 2.04
Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc Natl Acad Sci U S A (2000) 2.03
Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury. J Clin Invest (2009) 2.01
Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J Immunol (2010) 1.98
Identification and functional characterization of dendritic cells in the healthy murine kidney and in experimental glomerulonephritis. J Am Soc Nephrol (2004) 1.94
Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells. J Immunol (2007) 1.88
Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum (2000) 1.84
Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J Immunol (2008) 1.79
IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice. J Immunol (1997) 1.78
IL-17 and the Th17 lineage in systemic lupus erythematosus. Curr Opin Rheumatol (2008) 1.73
IL-10 regulates murine lupus. J Immunol (2002) 1.70
Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis. J Exp Med (2004) 1.70
Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease. Adv Immunol (2006) 1.69
Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis. J Exp Med (1997) 1.63
Mature dendritic cells readily break tolerance in normal mice but do not lead to disease expression. Arthritis Rheum (2005) 1.63
Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int (1987) 1.60
Severe defects in immunity and hematopoiesis caused by SHP-1 protein-tyrosine-phosphatase deficiency. Trends Biotechnol (1997) 1.47
Lupus, DNase and defective disposal of cellular debris. Nat Genet (2000) 1.47
T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells. J Clin Invest (2005) 1.45
NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci. Clin Immunol (2001) 1.42
Immature myeloid and plasmacytoid dendritic cells infiltrate renal tubulointerstitium in patients with lupus nephritis. Mol Immunol (2007) 1.39
Failed self-tolerance and autoimmunity in IgG anti-DNA transgenic mice. J Immunol (1992) 1.35
T cells in the pathogenesis of systemic lupus erythematosus. Clin Immunol (2004) 1.34
Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages. Proc Natl Acad Sci U S A (2010) 1.33
Act1 modulates autoimmunity through its dual functions in CD40L/BAFF and IL-17 signaling. Cytokine (2007) 1.31
Adoptive transfer studies demonstrate that macrophages can induce proteinuria and mesangial cell proliferation. Kidney Int (2003) 1.30
Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus. J Rheumatol (2003) 1.30
Anti-DNA antibodies in the pathogenesis of lupus nephritis--the emerging mechanisms. Autoimmun Rev (2007) 1.27
Pathogenic profiles and molecular signatures of antinuclear autoantibodies rescued from NZM2410 lupus mice. J Exp Med (2004) 1.22
Experimental anti-GBM disease as a tool for studying spontaneous lupus nephritis. Clin Immunol (2007) 1.21
Intrinsic renal cells are the major source of tumor necrosis factor contributing to renal injury in murine crescentic glomerulonephritis. J Am Soc Nephrol (2003) 1.19
Role for nephritogenic T cells in lupus glomerulonephritis: progression to renal failure is accompanied by T cell activation and expansion in regional lymph nodes. J Immunol (2006) 1.09
IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease. Proc Natl Acad Sci U S A (2003) 1.06
Role of oxidants and proteases in glomerular injury. Kidney Int (1994) 1.00
Plasma levels of nucleosomes and nucleosome-autoantibody complexes in murine lupus: effects of disease progression and lipopolyssacharide administration. Arthritis Rheum (2001) 1.00
Enrichment of anti-glomerular antigen antibody-producing cells in the kidneys of MRL/MpJ-Fas(lpr) mice. J Immunol (2004) 0.98
Podocyte expression of MHC class I and II and intercellular adhesion molecule-1 (ICAM-1) in experimental pauci-immune crescentic glomerulonephritis. Clin Exp Immunol (1994) 0.97
Major histocompatibility complex class II expression by intrinsic renal cells is required for crescentic glomerulonephritis. J Exp Med (1998) 0.96
IL-4 and many roads to lupuslike autoimmunity. Clin Immunol (2003) 0.95
TWEAK stimulation of kidney resident cells in the pathogenesis of graft versus host induced lupus nephritis. Immunol Lett (2009) 0.94
T cells in murine lupus: propagation and regulation of disease. Mol Biol Rep (1996) 0.91
Dendritic cells and the immunopathogenesis of systemic lupus erythematosus. Immunol Res (2007) 0.90
Synthetic CpG oligodeoxynucleotides accelerate the development of lupus nephritis during preactive phase in NZB x NZWF1 mice. Lupus (2003) 0.88
Decreased numbers of monocytes in inflammatory exudates in systemic lupus erythematosus. J Rheumatol (1981) 0.87
Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon. Exp Nephrol (1995) 0.87
Loss of tolerance of anti-dsDNA B cells in mice overexpressing CD19. Mol Immunol (2006) 0.86
Macrophages prevent the differentiation of autoreactive B cells by secreting CD40 ligand and interleukin-6. Blood (2007) 0.86
TNF-alpha enhances colony-stimulating factor-1-induced macrophage accumulation in autoimmune renal disease. J Immunol (1996) 0.86
Cutting edge: B cells promote CD8+ T cell activation in MRL-Fas(lpr) mice independently of MHC class I antigen presentation. J Immunol (2000) 0.86
Interleukin-4 transgenic mice develop glomerulosclerosis independent of immunoglobulin deposition. Eur J Immunol (2000) 0.84
Cytokines in glomerulonephritis. Semin Nephrol (2007) 0.80
Soluble interferon-gamma receptor: a therapeutically useful drug for systemic lupus erythematosus. J Interferon Res (1994) 0.76
B7(+)-transfectant tubular epithelial cells induce T cell anergy, ignorance or proliferation. Kidney Int (1994) 0.76
Regulation of B cell tolerance by the lupus susceptibility gene Ly108. Science (2006) 2.58
Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity. Immunity (2008) 2.48
Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J Clin Invest (2005) 2.36
Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proc Natl Acad Sci U S A (2009) 2.31
DGKE variants cause a glomerular microangiopathy that mimics membranoproliferative GN. J Am Soc Nephrol (2012) 1.93
The green tea polyphenol (-)-epigallocatechin-3-gallate ameliorates experimental immune-mediated glomerulonephritis. Kidney Int (2011) 1.72
Use of a novel elution regimen reveals the dominance of polyreactive antinuclear autoantibodies in lupus kidneys. Arthritis Rheum (2003) 1.63
Excreted urinary mediators in an animal model of experimental immune nephritis with potential pathogenic significance. Arthritis Rheum (2007) 1.62
Toll-like receptor signaling pathways--therapeutic opportunities. Mediators Inflamm (2010) 1.58
Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans. J Clin Invest (2009) 1.54
Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice. J Autoimmun (2009) 1.51
Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis. J Immunol (2007) 1.49
Requirement of myeloid cell-specific Fas expression for prevention of systemic autoimmunity in mice. Arthritis Rheum (2012) 1.48
T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells. J Clin Invest (2005) 1.45
Strain distribution pattern of susceptibility to immune-mediated nephritis. J Immunol (2004) 1.34
SLE peripheral blood B cell, T cell and myeloid cell transcriptomes display unique profiles and each subset contributes to the interferon signature. PLoS One (2013) 1.25
Lupus susceptibility genes may breach tolerance to DNA by impairing receptor editing of nuclear antigen-reactive B cells. J Immunol (2007) 1.22
Pathogenic profiles and molecular signatures of antinuclear autoantibodies rescued from NZM2410 lupus mice. J Exp Med (2004) 1.22
Genetic dissection of SLE: SLE1 and FAS impact alternate pathways leading to lymphoproliferative autoimmunity. J Exp Med (2002) 1.22
CXCR4/CXCL12 hyperexpression plays a pivotal role in the pathogenesis of lupus. J Immunol (2009) 1.22
Experimental anti-GBM disease as a tool for studying spontaneous lupus nephritis. Clin Immunol (2007) 1.21
Enhanced susceptibility to end-organ disease in the lupus-facilitating NZW mouse strain. Arthritis Rheum (2003) 1.18
Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol (2011) 1.17
Metabolic disturbances associated with systemic lupus erythematosus. PLoS One (2012) 1.15
Shared signaling networks active in B cells isolated from genetically distinct mouse models of lupus. J Clin Invest (2007) 1.14
Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells. Arthritis Rheum (2006) 1.14
Innate stimuli accentuate end-organ damage by nephrotoxic antibodies via Fc receptor and TLR stimulation and IL-1/TNF-alpha production. J Immunol (2006) 1.13
Urine VCAM-1 as a marker of renal pathology activity index in lupus nephritis. Arthritis Res Ther (2012) 1.10
Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis. J Immunol (2009) 1.04
Macrophage subpopulations in systemic lupus erythematosus. Discov Med (2012) 1.02
Molecular basis of 9G4 B cell autoreactivity in human systemic lupus erythematosus. J Immunol (2013) 1.00
Urine proteome scans uncover total urinary protease, prostaglandin D synthase, serum amyloid P, and superoxide dismutase as potential markers of lupus nephritis. J Immunol (2010) 0.99
Adverse effects of simulated hyper- and hypo-phosphatemia on endothelial cell function and viability. PLoS One (2011) 0.99
Proteomic toolbox for autoimmunity research. Autoimmun Rev (2009) 0.98
Lupus nephritis: current update. Arthritis Res Ther (2011) 0.97
The lupus-susceptibility locus, Sle3, mediates enhanced resistance to bacterial infections. J Immunol (2006) 0.97
Dysregulated expression of CXCR4/CXCL12 in subsets of patients with systemic lupus erythematosus. Arthritis Rheum (2010) 0.95
The lupus susceptibility locus Sle1 breaches peripheral B cell tolerance at the antibody-forming cell and germinal center checkpoints. J Immunol (2009) 0.95
Kallikrein transduced mesenchymal stem cells protect against anti-GBM disease and lupus nephritis by ameliorating inflammation and oxidative stress. PLoS One (2013) 0.95
Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus. Expert Opin Ther Targets (2009) 0.94
Experimental anti-GBM nephritis as an analytical tool for studying spontaneous lupus nephritis. Arch Immunol Ther Exp (Warsz) (2008) 0.94
The lupus-prone NZM2410/NZW strain-derived Sle1b sublocus alters the germinal center checkpoint in female mice in a B cell-intrinsic manner. J Immunol (2012) 0.94
Enhanced egg-induced immunopathology correlates with high IFN-gamma in murine schistosomiasis: identification of two epistatic genetic intervals. J Immunol (2005) 0.93
Deficiency of type I interferon contributes to Sle2-associated component lupus phenotypes. Arthritis Rheum (2005) 0.93
Modulating proximal cell signaling by targeting Btk ameliorates humoral autoimmunity and end-organ disease in murine lupus. Arthritis Res Ther (2012) 0.92
PI3K/AKT signaling and systemic autoimmunity. Immunol Res (2005) 0.92
What do mouse models teach us about human SLE? Clin Immunol (2006) 0.92
Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss. J Clin Immunol (2006) 0.92
SLE 1, 2, 3...genetic dissection of lupus. Adv Exp Med Biol (2007) 0.92
The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosus. J Interferon Cytokine Res (2011) 0.91
Inflammation associated anemia and ferritin as disease markers in SLE. Arthritis Res Ther (2012) 0.90
Urinary angiostatin--a novel putative marker of renal pathology chronicity in lupus nephritis. Mol Cell Proteomics (2013) 0.90
The AKT axis as a therapeutic target in autoimmune diseases. Endocr Metab Immune Disord Drug Targets (2009) 0.90
Latent membrane protein 1, the EBV-encoded oncogenic mimic of CD40, accelerates autoimmunity in B6.Sle1 mice. J Immunol (2010) 0.89
Genetic dissection of systemic lupus erythematosus pathogenesis: evidence for functional expression of Sle3/5 by non-T cells. J Immunol (2002) 0.89
PI3K/AKT/mTOR hypersignaling in autoimmune lymphoproliferative disease engendered by the epistatic interplay of Sle1b and FASlpr. Int Immunol (2007) 0.88
Superoxide dismutase mimetic drug tempol aggravates anti-GBM antibody-induced glomerulonephritis in mice. Am J Physiol Renal Physiol (2010) 0.88
Anti-nuclear antibody reactivity in lupus may be partly hard-wired into the primary B-cell repertoire. Mol Immunol (2009) 0.87
IgG and IgM autoantibody differences in discoid and systemic lupus patients. J Invest Dermatol (2012) 0.87
Molecular signatures of antinuclear antibodies-contributions of heavy chain CDR residues. Mol Immunol (2002) 0.87
Strain distribution pattern of immune nephritis--a follow-up study. Int Immunol (2008) 0.85
Overexpression of membrane-bound fas ligand (CD95L) exacerbates autoimmune disease and renal pathology in pristane-induced lupus. J Immunol (2013) 0.85
CD19 hyperexpression augments Sle1-induced humoral autoimmunity but not clinical nephritis. Arthritis Rheum (2007) 0.85
Altered B-cell signaling in lupus. Autoimmun Rev (2008) 0.84
The lipopolysaccharide-triggered mesangial transcriptome: Evaluating the role of interferon regulatory factor-1. Kidney Int (2005) 0.84
Prevention of murine lupus nephritis by targeting multiple signaling axes and oxidative stress using a synthetic triterpenoid. Arthritis Rheumatol (2014) 0.83
Urinary vascular cell adhesion molecule, but not neutrophil gelatinase-associated lipocalin, is associated with lupus nephritis. J Rheumatol (2012) 0.83
Glutathione S-transferase Mu 2-transduced mesenchymal stem cells ameliorated anti-glomerular basement membrane antibody-induced glomerulonephritis by inhibiting oxidation and inflammation. Stem Cell Res Ther (2014) 0.82
Molecular signatures of anti-nuclear antibodies: contributions of specific light chain residues and a novel New Zealand Black V kappa 1 germline gene. J Immunol (2003) 0.82
RANTES deficiency attenuates autoantibody-induced glomerulonephritis. J Clin Immunol (2010) 0.82
Systemic lupus erythematosus--recent clues from congenic strains. Arch Immunol Ther Exp (Warsz) (2005) 0.81
Understanding B-cell tolerance through the use of immunoglobulin transgenic models. Immunol Res (2008) 0.81
Proteomics in rheumatology: the dawn of a new era. F1000 Med Rep (2010) 0.81
Genetic basis of murine lupus nephritis. Semin Nephrol (2007) 0.81
Enhanced expression of stem cell antigen-1 (Ly-6A/E) in lymphocytes from lupus prone mice correlates with disease severity. J Autoimmun (2005) 0.80
Natural trematode infection in liver of water buffalo (Bubalus bubalis): histopathological investigation. J Parasit Dis (2011) 0.80
Macrophages and neutrophils in SLE-An online molecular catalog. Autoimmun Rev (2011) 0.80
Identification of novel VH1/J558 immunoglobulin germline genes of C57BL/6 (Igh b) allotype. Mol Immunol (2005) 0.80
Serial non-invasive assessment of antibody induced nephritis in mice using positron emission tomography. PLoS One (2013) 0.80
Molecular signatures of anti-nuclear antibodies--contribution of heavy chain framework residues. Mol Immunol (2003) 0.79
Inducible expression of kallikrein in renal tubular cells protects mice against spontaneous lupus nephritis. Arthritis Rheum (2013) 0.79
Serial non-invasive monitoring of renal disease following immune-mediated injury using near-infrared optical imaging. PLoS One (2012) 0.79
Paraquat Poisoning Followed by Toxic Epidermal Necrolysis: A Report of Two Cases and Published Work Review. Dermatology (2015) 0.79
Molecular hallmarks of anti-chromatin antibodies associated with the lupus susceptibility locus, Sle1. Mol Immunol (2009) 0.78
Genetic underpinnings of autoimmunity--lessons from studies in arthritis, diabetes, lupus and multiple sclerosis. Curr Opin Immunol (2003) 0.78
Protein kinase Cβ is required for lupus development in Sle mice. Arthritis Rheum (2013) 0.78
Three pathogenic determinants in immune nephritis--anti-glomerular antibody specificity, innate triggers and host genetics. Front Biosci (2007) 0.77
The role of rearrangement at the second Ig heavy chain locus in maintaining B cell tolerance to DNA. J Immunol (2008) 0.77
Enhanced susceptibility to immune nephritis in DBA/1 mice is contingent upon IL-1 expression. Clin Immunol (2007) 0.77
Proteomics on the diagnostic horizon: Lessons from rheumatology. Am J Med Sci (2007) 0.77
Genetics: Rare genes for autoimmunity-the new kids on the block. Nat Rev Rheumatol (2010) 0.76
Lupus nephritis - alarmins may sound the alarm? Arthritis Res Ther (2012) 0.76
Pneumomediastinum predicts early mortality in acute paraquat poisoning. Clin Toxicol (Phila) (2015) 0.76
Analysis of autophagosome formation using lentiviral biosensors for live fluorescent cellular imaging. Methods Mol Biol (2015) 0.76
Biomarkers of rheumatoid arthritis: recent progress. Expert Opin Med Diagn (2010) 0.76
Melanocortin-4-receptor autoantibodies: a new player in obesity. J Clin Endocrinol Metab (2009) 0.75
Divide and conquer--the power of congenic strains. Clin Immunol (2004) 0.75
Peritoneal catheter implantation elicits IL-10-producing immune-suppressor macrophages through a MyD88-dependent pathway. Clin Immunol (2012) 0.75
Treatment Outcome of Combined Continuous Venovenous Hemofiltration and Hemoperfusion in Acute Paraquat Poisoning: A Prospective Controlled Trial. Crit Care Med (2017) 0.75